Send feedback

NBAS p.Ser180Arg

c.540C>G · rs202027230 · VCV1379399

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.788 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.033%, mid)
Missense predictors
1/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.788likely pathogenic
REVEL0.251benign-leaning
SaProtLLR -7.89tolerated
⇒ AlphaMissense calls this damaging; REVEL and SaProt do not.
Splicing
SpliceAI—not assessed · no allele here is in the release
PangolinΔ0.24loss · gain 0.05 · not in the SpliceAI release · independent
Constraint at this position
ConservationphyloP 5.8GERP 0.94, phastCons 1
Regional constrainto/e 1.03unconstrained · MANE · 394 kb · p 0.09 · regional, not allelic
Overall
CADD24.2PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.033% Middle Eastern · 2/6,062 alleles
Filtering AF 0.00582% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00295%
Overall 0.00503% 81/1,611,414 alleles · ultra-rare exomes 74/1,459,754 · genomes 7/151,660 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.139% 722
Middle Easterngrpmax 0.033% 3,031
Remaining individualsnot grpmax-eligible 0.0128% 7,810
Admixed American 0.01% 9,993
South Asian 0.0022% 45,519
European (non-Finnish) 0.00187% 53,605

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
NBAS
Protein
p.Ser180Arg
Coding
c.540C>G
MANE Select
NM_015909
dbSNP
rs202027230
Type
single nucleotide variant
Location
chr2:15536525 (GRCh38)
Gene constraint
LOEUF 0.761 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 74.42
Residue 180
the 'interaction with use1' region
Full NBAS gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nbas-p-ser180arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown